StockNews.com started coverage on shares of Veradigm (NASDAQ:MDRX – Free Report) in a report released on Saturday morning. The firm issued a hold rating on the software maker’s stock.
Veradigm Stock Performance
Shares of NASDAQ:MDRX opened at $11.11 on Friday. Veradigm has a 12-month low of $5.01 and a 12-month high of $13.22. The company’s 50 day moving average price is $9.51 and its two-hundred day moving average price is $9.27.
Hedge Funds Weigh In On Veradigm
An institutional investor recently bought a new position in Veradigm stock. Tyro Capital Management LLC purchased a new position in Veradigm Inc. (NASDAQ:MDRX – Free Report) during the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 1,176,015 shares of the software maker’s stock, valued at approximately $9,055,000. Veradigm accounts for 5.2% of Tyro Capital Management LLC’s investment portfolio, making the stock its 10th largest position. Tyro Capital Management LLC owned approximately 1.08% of Veradigm as of its most recent filing with the Securities and Exchange Commission (SEC).
Veradigm Company Profile
Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.
Recommended Stories
- Five stocks we like better than Veradigm
- What is Insider Trading? What You Can Learn from Insider Trading
- Home Depot Stock: Targeting 12% in 2024 and 25% More in 2025
- Insider Buying Explained: What Investors Need to Know
- Is Tesla’s Valuation a Bubble or Backed by Real Growth?
- How to Start Investing in Real Estate
- Trucking Stocks Led the Pack Last Week: Can They Keep Rolling?
Receive News & Ratings for Veradigm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veradigm and related companies with MarketBeat.com's FREE daily email newsletter.